Press Releases
Press Releases
Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility
Thermo Fisher Scientific, the world leader in serving science, unveiled the $6 million expansion of its gene therapy and viral vector services site in Alachua, Florida. The investment doubles the siteโs laboratory and warehousing capacity for upstream process development...
Press Releases
Novartis opens new cell and gene therapies facility in Switzerland
Swiss pharmaceutical company Novartis has opened a new manufacturing facility for cell and gene therapies at Stein in Switzerland.
The new facility also facilitates the production of advanced and difficult-to-manufacture solid dosage forms such as tablets and capsules, in addition...
Press Releases
Recipharm announces commercial manufacturing to support Taliciaยฎ Q1/2020 launch following U.S. FDA approval
Recipharm, the contract development and manufacturing organisation , announced ongoing large-scale commercial manufacturing of RedHill Biopharmaโs drug, Talicia delayed-release capsules 10 mg /250 mg/12.5 mg, for its planned launch in the first quarter 2020.
RedHill and Recipharm have been working...
Drug Research
Aptar Pharma, Platinum Sponsor at DDL 2019, to Showcase Expanded Portfolio of Respiratory Innovations and Services
Aptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this yearโs Drug Delivery to the Lung (DDL) Conference 2019, which takes place from December 11-13 in Edinburgh, Scotland.
DDL provides an annual forum for scientists, academics,...
Packaging & Labelling
Turkish Cargo expands the Pharma Corridor in its wide flight network
Turkish Cargo, the fastest growing global air cargo brand thanks to its wide flight network, keeps bringing health to the world by carrying pharmaceuticals between destinations certified by the global aviation authorities.
The successful brand has created a pharma corridor...
Clinical Trials
Anixa Biosciences collaborates with Urology Centers of Alabama on Cchek early prostate cancer detection study
Anixa Biosciences, Inc., a biotechnology company, announced a collaboration with Urology Centers of Alabama (UCA) in the Cchek early prostate cancer detection study. UCA will provide patient samples in Anixa's ongoing study, including support of clinical validation of Anixa's...
Clinical Trials
Biogen completes enrollment in phase 3 STAR study of gene therapy timrepigene emparvovec to treat inherited retinal disorder
Biogen Inc, a global biotechnology company, announced the enrollment of the last patient in the global phase 3 STAR clinical study, which is evaluating the investigational gene therapy timrepigene emparvovec (BIIB111/AAV2-REP1) for the treatment of choroideremia (CHM). CHM is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















